Literature DB >> 21913914

Homogenous phenomenon of graft liver CYP2C19 genotypes after living donor liver transplantation.

King-Wah Chiu1, Toshiaki Nakano, Tsung-Hui Hu, Hui-Peng Tseng, Yu-Fan Cheng, Bruno Jawan, Hock-Liew Eng, Shigeru Goto, Chao-Long Chen.   

Abstract

BACKGROUND: The donor liver grafts with different allelic patterns do not affect CYP2C19 genotypes in the peripheral blood of living donor liver transplantation (LDLT) recipients. AIM: This study investigated the influence of graft liver CYP2C19 genotypes on recipients who received the same or different CYP2C19 genotypes from donors after LDLT.
METHODS: There were 30 donors and 30 recipients with the same CYP2C19 genotypes and 47 donors and 47 recipients with different CYP2C19 genotypes. Genomic DNA was isolated from the liver tissue of recipients. The CYP2C19 haplotypes were determined by polymerase chain reaction.
RESULTS: A homogenous phenomenon in the sequences of graft liver CYP2C19 genotypes was indicated because the recipients showed mixed patterns that were similar to that of the original donor after LDLT. A significant decrease in homozygous extensive metabolizer (HomEM) and an increase in poor metabolizer (PM) distribution were observed in recipients with different CYP2C19 genotypes from their donors compared with recipients with the same CYP2C19 genotype as their donors (P < 0·05).
CONCLUSIONS: Homogenous phenomenon of sequence changes in graft liver CYP2C19 from the different genotypes between the donors and the recipients may play a role in graft stability by causing decreased HomEM and increased PM after LDLT.
© 2011 The Authors. European Journal of Clinical Investigation © 2011 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21913914     DOI: 10.1111/j.1365-2362.2011.02589.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  10 in total

1.  Homogeneous phenomenon of the graft when using different genotype characteristic of recipients/donors in living donor liver transplantation.

Authors:  King-Wah Chiu; Toshiaki Nakano; Kuang-Den Chen; Li-Wen Hsu; Chia-Yun Lai; Ho-Ching Chiu; Ching-Yin Huang; Yu-Fan Cheng; Shigeru Goto; Chao-Long Chen
Journal:  World J Hepatol       Date:  2013-11-27

2.  Observational Study of Associations between Voriconazole Therapeutic Drug Monitoring, Toxicity, and Outcome in Liver Transplant Patients.

Authors:  Zahra Hashemizadeh; Parisa Badiee; Seyed Ali Malekhoseini; Hadi Raeisi Shahraki; Bita Geramizadeh; Hashem Montaseri
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

3.  Liver Graft Pathology and Low Serum 25-Hydroxyvitamin D after Living Donor Liver Transplantation.

Authors:  Shu-Hsien Lin; Chih-Chi Wang; Kuang-Tzu Huang; Kuang-Den Chen; Li-Wen Hsu; Hock-Liew Eng; King-Wah Chiu
Journal:  Metabolites       Date:  2022-04-25

4.  The Genotype Frequency of CYP2C19 Enzyme after Liver Transplantation.

Authors:  P Badiee; Z Hashemizadeh; S A Malek-Hosseini; B Geramizadeh
Journal:  Int J Organ Transplant Med       Date:  2019-05-01

5.  Repeated-measures implication of hepatocellular carcinoma biomarkers in living donor liver transplantation.

Authors:  King-Wah Chiu; Toshiaki Nakano; Kuang-Den Chen; Li-Wen Hsu; Chia-Yun Lai; Ching-Yin Huang; Yu-Fan Cheng; Shigeru Goto; Chao-Long Chen
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

Review 6.  Cytochrome P450 in living donor liver transplantation.

Authors:  King-Wah Chiu; Toshiaki Nakano; Kuang-Den Chen; Li-Wen Hsu; Chia-Yun Lai; Ching-Yin Huang; Yu-Fan Cheng; Shigeru Goto; Chao-Long Chen
Journal:  J Biomed Sci       Date:  2015-05-15       Impact factor: 8.410

7.  Pyrosequencing to identify homogeneous phenomenon when using recipients/donors with different CYP3A5*3 genotypes in living donor liver transplantation.

Authors:  King-Wah Chiu; Toshiaki Nakano; Kuang-Den Chen; Chia-Yun Lai; Li-Wen Hsu; Ho-Ching Chiu; Ching-Yin Huang; Yu-Fan Cheng; Shigeru Goto; Chao-Long Chen
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

8.  Association of IL28B SNPs rs12979860 and rs8099917 on Hepatitis C Virus-RNA Status in Donors/Recipients of Living Donor Liver Transplantation.

Authors:  King-Wah Chiu; Toshiaki Nakano; Kuang-Den Chen; Chih-Che Lin; Tsung-Hui Hu; Shigeru Goto; Chao-Long Chen
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

9.  Biological interactions of CYP2C19 genotypes with CYP3A4*18, CYP3A5*3, and MDR1-3435 in living donor liver transplantation recipients.

Authors:  King-Wah Chiu; Tsung-Hui Hu; Toshiaki Nakano; Kuang-Den Chen; Chia-Yun Lai; Li-Wen Hsu; Hui-Peng Tseng; Ho-Ching Chiu; Yu-Fan Cheng; Shigeru Goto; Chao-Long Chen
Journal:  Transplant Res       Date:  2013-04-23

10.  Association between Subclinical Low Serum 25(OH)D in Donors and Fatty Liver Disease in Recipients after Living Donor Liver Transplantation.

Authors:  King-Wah Chiu; Toshiaki Nakano; Tsung-Hui Hu; Kuang-Den Chen; Li-Wen Hsu; Hock-Liew Eng; Yu-Fan Cheng; Shigeru Goto; Chao-Long Chen
Journal:  Biomed Res Int       Date:  2018-03-19       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.